financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Nutanix, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Nutanix, Inc.
Mar 4, 2024 11:01 PM

01:00 PM EST, 02/29/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our target to $71 from $47 on a P/S of 7.5x, above its three-year average on good sales execution and a favorable deal pipeline, using our next-12-month sales estimate of $2.3B. We lift our FY 24 EPS view to $1.07 from $0.95 and FY 25's to $1.33 from $1.21. NTNX posted Q2 sales of $565.2M, above consensus by $14.8M, while non-GAAP EPS of $0.46 beat by $0.17. Revenue rose 16.2% Y/Y from solid Subscription revenue growth (+18% Y/Y) as ACV billings outperformed, up 23% Y/Y, from higher-than-anticipated renewals. We note NTNX's commentary around a continued uncertain macro environment, and longer average sales cycles, which likely impacted contract duration of 2.8 years in Q2, lower than Q1. However, these results reflect the firm's strong execution in securing and keeping pace with renewals and expansion deals, as well as maintaining healthy pricing levels in spite of these challenges. Its upbeat guidance and a higher mix of large deals in the pipeline further support our positive view of the business.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Apa Corporation
Research Alert: CFRA Keeps Hold Opinion On Shares Of Apa Corporation
Aug 8, 2025
03:05 AM EDT, 08/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target of $22, up $3, reflects a 2.8x multiple of enterprise value to projected 2026 EBITDA, below APA's historical forward average. We think the discount is reasonable in...
Research Alert: CFRA Reiterates Sell Opinion On Shares Of Nutrien Ltd.
Research Alert: CFRA Reiterates Sell Opinion On Shares Of Nutrien Ltd.
Aug 7, 2025
12:55 AM EDT, 08/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target by CAD6 to CAD69, 5.9x our 2026 EBITDA estimate of USD5.8B, below its three-year average forward EV/EBITDA of 6.4x. We increase our 2025 EPS view...
Research Alert: CFRA Upholds Sell Opinion On Shares Of Dayforce Inc.
Research Alert: CFRA Upholds Sell Opinion On Shares Of Dayforce Inc.
Aug 8, 2025
03:20 AM EDT, 08/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After Q2 earnings, we keep our $46 target price, based on a P/E of 18.6x our 2026 EPS estimate, below its historical avg. and that of its peers, given our...
Research Alert: CFRA Reiterates Sell Opinion On Shares Of Nutrien Ltd.
Research Alert: CFRA Reiterates Sell Opinion On Shares Of Nutrien Ltd.
Aug 7, 2025
12:50 AM EDT, 08/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target by $5 to $50, 5.9x our 2026 EBITDA estimate of $5.8B, below its three-year average forward EV/EBITDA of 6.4x. We increase our 2025 EPS view...
Copyright 2023-2026 - www.financetom.com All Rights Reserved